90 related articles for article (PubMed ID: 11053987)
1. Oral doxifluridine in advanced hepatocellular carcinoma: A phase II study.
Lencioni M; Falcone A; Allegrini G; Pfanner E; Masi G; Brunetti I; Di Marsico R; Fontana E; Orlandini C; Stampino CG; Bartolozzi C; Conte PF
Oncology; 2000 Sep; 59(3):204-9. PubMed ID: 11053987
[TBL] [Abstract][Full Text] [Related]
2. Oral doxifluridine in elderly patients with metastatic colorectal cancer: a multicenter phase II study.
Falcone A; Pfanner E; Ricci S; Bertuccelli M; Cianci C; Carrai M; De Marco S; Ceribelli A; Barduagni M; Calabresi F
Ann Oncol; 1994 Oct; 5(8):760-2. PubMed ID: 7826910
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancer.
Baldini E; Tibaldi C; Pfanner E; Ricci S; Falcone A; Ceribelli A; Sarcina R; Comella G; Stampino CG; Conte PF
Am J Clin Oncol; 1996 Dec; 19(6):592-4. PubMed ID: 8931679
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of doxifluridine in advanced squamous cell carcinoma of the head and neck.
Abele R; Kaplan E; Grossenbacher R; Schmid HJ; Cavalli F
Eur J Cancer Clin Oncol; 1984 Mar; 20(3):333-6. PubMed ID: 6231185
[TBL] [Abstract][Full Text] [Related]
5. 5-Fluorouracil and d,l-leucovorin calcium are active to treat unresectable hepatocellular carcinoma patients: preliminary results of a phase II study.
Porta C; Moroni M; Nastasi G; Arcangeli G
Oncology; 1995; 52(6):487-91. PubMed ID: 7478436
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of nolatrexed dihydrochloride [Thymitaq, AG 337] in patients with advanced hepatocellular carcinoma.
Jhawer M; Rosen L; Dancey J; Hochster H; Hamburg S; Tempero M; Clendeninn N; Mani S
Invest New Drugs; 2007 Feb; 25(1):85-94. PubMed ID: 16957834
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgery.
Tominaga T; Koyama H; Toge T; Miura S; Sugimachi K; Yamaguchi S; Hirata K; Monden Y; Nomura Y; Toi M; Kimijima I; Noguchi S; Sonoo H; Asaishi K; Ikeda T; Morimoto T; Ota J; Ohashi Y; Abe O
J Clin Oncol; 2003 Mar; 21(6):991-8. PubMed ID: 12637462
[TBL] [Abstract][Full Text] [Related]
8. Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinoma.
Cheng AL; Chen YC; Yeh KH; Chuang SE; Chen BR; Chen DS
Cancer; 1996 Mar; 77(5):872-7. PubMed ID: 8608477
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of doxifluridine in elderly patients with advanced gastric cancer: the Japan Clinical Oncology Group Study (JCOG 9410).
Ikeda N; Shimada Y; Ohtsu A; Boku N; Tsuji Y; Saito H; Koizumi W; Iwase H; Yoshida S; Fukuda H
Jpn J Clin Oncol; 2002 Mar; 32(3):90-4. PubMed ID: 11956303
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of oral doxifluridine in patients with colorectal cancer.
Zampino MG; Colleoni M; Bajetta E; Stampino CG; Guenzi A; de Braud F
Tumori; 1999; 85(1):47-50. PubMed ID: 10228497
[TBL] [Abstract][Full Text] [Related]
11. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
[TBL] [Abstract][Full Text] [Related]
12. A Phase II trial of nolatrexed dihydrochloride in patients with advanced hepatocellular carcinoma.
Stuart K; Tessitore J; Rudy J; Clendennin N; Johnston A
Cancer; 1999 Aug; 86(3):410-4. PubMed ID: 10430248
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of irinotecan in combination with doxifluridine, an intermediate form of capecitabine, in patients with metastatic colorectal cancer.
Kato T; Mishima H; Ikenaga M; Murata K; Ishida H; Fukunaga M; Ota H; Tominaga S; Ohnishi T; Amano M; Ikeda K; Ikeda M; Sekimoto M; Sakamoto J; Monden M
Cancer Chemother Pharmacol; 2008 Feb; 61(2):275-81. PubMed ID: 17429630
[TBL] [Abstract][Full Text] [Related]
14. A combination phase I study of weekly paclitaxel and doxifluridine in advanced gastric cancer patients.
Takeyoshi I; Makita F; Tanahashi Y; Yokomori T; Iwazaki S; Kawashima Y; Iwanami K; Yamada T; Kawate S; Hamada K; Sunose Y; Yoshida M; Horiguchi J; Iesato H; Kobayashi M; Morishita Y
Anticancer Res; 2005; 25(2B):1291-6. PubMed ID: 15865080
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinoma.
Zhu AX; Fuchs CS; Clark JW; Muzikansky A; Taylor K; Sheehan S; Tam K; Yung E; Kulke MH; Ryan DP
Oncologist; 2005; 10(6):392-8. PubMed ID: 15967833
[TBL] [Abstract][Full Text] [Related]
16. A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors.
Saeki T; Takashima S; Terashima M; Satoh A; Toi M; Osaki A; Toge T; Ohno S; Nomura N; Fukuyama Y; Koizumi W; Taguchi T
Int J Clin Oncol; 2005 Feb; 10(1):51-7. PubMed ID: 15729602
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of doxifluridine in advanced colorectal adenocarcinoma.
Abele R; Alberto P; Kaplan S; Siegenthaler P; Hofmann V; Ryssel HJ; Hartmann D; Holdener EE; Cavalli F
J Clin Oncol; 1983 Dec; 1(12):750-4. PubMed ID: 6230419
[TBL] [Abstract][Full Text] [Related]
18. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
19. A phase I-II study of oral doxifluridine plus radiotherapy in radiosensitive tumors of the pelvic region.
Spagnesi S; Ducci F; Laddaga M; Falcone A; Conte PF; Pandolfi A; Stampino CG
Tumori; 1993 Aug; 79(4):250-3. PubMed ID: 8249177
[TBL] [Abstract][Full Text] [Related]
20. Capecitabine for treatment of advanced hepatocellular carcinoma.
von Delius S; Lersch C; Mayr M; Stock K; Schulte-Frohlinde E; Schmid RM; Eckel F
Hepatogastroenterology; 2007 Dec; 54(80):2310-4. PubMed ID: 18265654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
